The Science 37 Metasite in Action: A Fully Decentralized Trial for a Rare Vascular Disorder
A biopharma company was planning a Phase III, randomized, double-blind, placebo-controlled clinical trial for a drug to treat a rare and serious vascular disorder. Learn how the Science 37 Metasite™:
- Made it easier for patients with a rare cardiovascular disease to participate from home
- Delivered high-quality, compliant data to support the sponsor’s regulatory submission
- Had 100% patient retention in the first 4 months
Discover how a virtual site reduced patient burden with remote clinical trial conduct and delivered high-quality, compliant data to support the sponsor’s regulatory submission.